Contact
Please use this form to send email to PR contact of this press release:
Xenon Announces Its Partner Genentech Has Advanced GDC-0310, a Second Nav1.7 Inhibitor for Pain, Into Clinical Development
TO:
Please use this form to send email to PR contact of this press release:
Xenon Announces Its Partner Genentech Has Advanced GDC-0310, a Second Nav1.7 Inhibitor for Pain, Into Clinical Development
TO: